The global medical device industry, expected to top $1.1 trillion by 2034, is facing increasing regulatory challenges that are slowing innovation. In the U.S., more than 80% of 510(k) submissions have quality issues, resulting in costly delays and re...
Want to read this article? Subscribe to TFN Prime at super early discounted price